News
Research reveals how specific sleep stages protect brain vulnerable to Alzheimer's, offering hope through simple lifestyle ...
Researchers at Cedars-Sinai have made an important discovery that could help doctors detect Alzheimer’s disease earlier and more easily—by studying the eyes. The team closely examined changes in the ...
Earlier studies have identified a relationship between sleep and Alzheimer’s disease. A new study looks in detail at sleep ...
The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...
It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...
A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease ...
New research finds that having unmanaged type 2 diabetes can cause similar symptoms to early Alzheimer's disease. Here's what ...
Ultrasound therapy is emerging as a potential treatment for Alzheimer’s disease. It uses ultrasound to open the blood-brain ...
A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...
Home > Pressemitteilung: Hereditary Alzheimer’s: Blood Marker ...
2h
Independent.ie on MSNFirst drug approved in EU to treat people with early Alzheimer’s diseaseThe first approved drug in the EU to treat patients in the early stages of Alzheimer’s disease has been given the go ahead after more than two years of review.The Alzheimer Society of Ireland (The ASI ...
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results